Literature DB >> 16825234

Did regulators fail over selective serotonin reuptake inhibitors?

David Healy1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16825234      PMCID: PMC1489234          DOI: 10.1136/bmj.333.7558.92

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

1.  The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.

Authors:  T P Laughren
Journal:  Eur Psychiatry       Date:  2001-11       Impact factor: 5.361

2.  Suicide risk in placebo-controlled studies of major depression.

Authors:  J G Storosum; B J van Zwieten; W van den Brink; B P Gersons; A W Broekmans
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

3.  SSRIs and deliberate self-harm.

Authors:  D Healy
Journal:  Br J Psychiatry       Date:  2002-06       Impact factor: 9.319

Review 4.  Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Authors:  Dean Fergusson; Steve Doucette; Kathleen Cranley Glass; Stan Shapiro; David Healy; Paul Hebert; Brian Hutton
Journal:  BMJ       Date:  2005-02-19

5.  A black-box warning for antidepressants in children?

Authors:  Thomas B Newman
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

6.  Emergence of intense suicidal preoccupation during fluoxetine treatment.

Authors:  M H Teicher; C Glod; J O Cole
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

7.  Beyond the confidence interval.

Authors:  C Poole
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

8.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.

Authors:  A Khan; S R Khan; R M Leventhal; W A Brown
Journal:  Int J Neuropsychopharmacol       Date:  2001-06       Impact factor: 5.176

9.  Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.

Authors:  Arif Khan; Shirin Khan; Russell Kolts; Walter A Brown
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

10.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.

Authors:  A Khan; H A Warner; W A Brown
Journal:  Arch Gen Psychiatry       Date:  2000-04
View more
  14 in total

1.  Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Authors:  Kay Dickersin; Iain Chalmers
Journal:  J R Soc Med       Date:  2011-12       Impact factor: 5.344

2.  Doctors as lapdogs to drug firms: the beast is ourselves.

Authors:  Aubrey Blumsohn
Journal:  BMJ       Date:  2006-11-25

Review 3.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

4.  Evidentiary Support in Public Comments to the FDA's Center for Tobacco Products.

Authors:  Natalie Hemmerich; Elizabeth G Klein; Micah Berman
Journal:  J Health Polit Policy Law       Date:  2017-05-08       Impact factor: 2.265

5.  Reply to the Letter to the Editor: "Newer-Generation Antidepressants and Suicide Risk: Thoughts on Hengartner and Plöderl's Re-Analysis".

Authors:  Michael P Hengartner; Martin Plöderl
Journal:  Psychother Psychosom       Date:  2019-09-05       Impact factor: 17.659

Review 6.  Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review.

Authors:  Peter C Gøtzsche; Pernille K Gøtzsche
Journal:  J R Soc Med       Date:  2017-10       Impact factor: 5.344

7.  Protecting the people?: risk communication and the chequered history and performance of bureaucracy.

Authors:  Bruce Hugman
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

8.  Our censored journals.

Authors:  David Healy
Journal:  Mens Sana Monogr       Date:  2008-01

9.  Why we need easy access to all data from all clinical trials and how to accomplish it.

Authors:  Peter C Gøtzsche
Journal:  Trials       Date:  2011-11-23       Impact factor: 2.279

Review 10.  Antidepressants and Suicide Risk: A Comprehensive Overview.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Elisa Ambrosi; Gloria Giordano; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.